Page last updated: 2024-09-03

fullerene c60 and Hematologic Malignancies

fullerene c60 has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Balin, K; Calvaresi, M; Korzuch, J; Malarz, K; Marforio, TD; Mrozek-Wilczkiewicz, A; Musiol, R; Serda, M1

Other Studies

1 other study(ies) available for fullerene c60 and Hematologic Malignancies

ArticleYear
Identification and Biological Evaluation of a Water-Soluble Fullerene Nanomaterial as BTK Kinase Inhibitor.
    International journal of nanomedicine, 2023, Volume: 18

    Topics: Agammaglobulinaemia Tyrosine Kinase; Antineoplastic Agents; Caspases; Fullerenes; Glycine; Hematologic Neoplasms; Humans; Neoplasms; Protein Kinase Inhibitors; Spectroscopy, Fourier Transform Infrared; Water

2023